Golden
Emerald Therapeutics

Emerald Therapeutics

Emerald Therapeutics is a biotechnology company located in San Fransisco, California, founded by Brian Frezza and DJ Klienbaum in 2010. Emerald Therapeutics offers cloud a based software and hardware platform that allows researchers to remotely perform automated scientific laboratory experiments.

All edits

Edits on 30 May 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May 2019 2:27 am
Edits made to:
Article (+11/-11 characters)

Article

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders Fund, and Max LevchinMax Levchin. 

Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May 2019 2:12 am
Edits made to:
Article (+29/-29 characters)

Article

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology InvestmentWestern Technology Investment, Sound Ventures, Schooner Capital, OS Fund, and Founders Fund. 

Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May 2019 2:11 am
Edits made to:
Article (+12/-12 characters)

Article

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay Area, California, and was founded in 2013 by Brian Frezza and DJ KleinbaumDJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab.

Jed Christiansen
Jed Christiansen approved a suggestion from Golden's AI on 29 May 2019 11:31 pm
Edits made to:
Article (+16/-16 characters)

Article

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner CapitalSchooner Capital, Founders Fund, and Max Levchin. 

Edits on 29 May 2019
Golden AI
Golden AI edited on 29 May 2019 2:58 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 28 Mar 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 28 Mar 2019 10:31 pm
Edits made to:
Article (+14/-14 characters)

Article

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound VenturesSound Ventures, Schooner Capital, OS Fund, and Founders Fund. 

Dawson Sewell
Dawson Sewell edited on 28 Mar 2019 10:16 pm
Edits made to:
Infobox (+10/-1 properties)
Timeline (+4 events) (+703 characters)
Article (+583/-583 characters)
Categories (+1/-1 topics)
Related Topics (+2 topics)

Article

Emerald Therapeutics is a biotechnologybiotechnology company located in the San Francisco Bay Area, California, and was founded in 20102013 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab. The Emerald Cloud Lab provides researchers control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups. 



The Emerald Cloud Lab provides researchers control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups. 

Infobox

Categories

Related Topics

Timeline

June 19, 2015

Series C funding round

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound Ventures, Schooner Capital, OS Fund, and Founders Fund. 

March 1, 2014

Series B funding round

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders Fund, and Max Levchin. 

December 27, 2010

Series A funding round

On December 27, 2010 Emerald Therapeutics announced their series A funding round and closed with $7,500,000 in funding from James Hong. 

2010

Founding of Emerald therapeutics

Emerald Therapeutics was founded in 2010 by Brian Frezza and DJ Kleinbaum

Edits on 4 Feb 2019
Golden AI"Import data"
Golden AI edited on 4 Feb 2019 11:07 pm
Edits made to:
Infobox (+1 properties)
People (+8 rows) (+16 cells) (+152 characters)

People

Name
Role
Related Golden topics

Ashby Monk

Investor



Eric Shyr

Employee



James Hong

Investor



James McKernan

Employee



John Tomcat Sanderson

Employee



Joi Ito

Investor



MJD MJD

Investor



Shan Sinha

Investor



Infobox

Edits on 16 Jan 2019
Golden AI"Import data"
Golden AI edited on 16 Jan 2019 7:56 pm
Edits on 9 Jan 2019
Golden AI
Golden AI edited on 9 Jan 2019 9:26 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 15 Aug 2018
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 15 Aug 2018 11:43 pm
Edits made to:
Article (+22/-22 characters)

Article

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay AreaSan Francisco Bay Area, California, and was founded in 2010 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab. The Emerald Cloud Lab provides researchers control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups. 

Edits on 15 Aug 2018
Dawson Sewell
Dawson Sewell edited on 15 Aug 2018 6:57 pm
Edits made to:
Description (+299/-209 characters)
Article (+2/-13 characters)
Topic thumbnail

Emerald Therapeutics

Emerald Therapeutics offers cloud a based software and hardware platform, called the Emerald Cloud Lab, that allows scientists to perform automated experiments in a centralized lab from anywhere in the world.

Emerald Therapeutics is a biotechnology company located in San Fransisco, California, founded by Brian Frezza and DJ Klienbaum in 2010. Emerald Therapeutics offers cloud a based software and hardware platform that allows researchers to remotely perform automated scientific laboratory experiments.

Article

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay Area, California , and was founded in 2010 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab. The Emerald Cloud Lab provides researchers with total control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups. 

Thomas Shaddox
Thomas Shaddox approved a suggestion from Golden's AI on 15 Aug 2018 6:44 pm
Edits made to:
Article (+10/-10 characters)

Article

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay Area, CaliforniaCalifornia and was founded in 2010 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab. The Emerald Cloud Lab provides researchers with total control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups.

Thomas Shaddox
Thomas Shaddox approved a suggestion from Golden's AI on 15 Aug 2018 6:42 pm
Edits made to:
Article (+7/-7 characters)

Article

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound Ventures, Schooner Capital, OS FundOS Fund, and Founders Fund. 

Thomas Shaddox
Thomas Shaddox approved a suggestion from Golden's AI on 15 Aug 2018 6:42 pm
Edits made to:
Article (+13/-13 characters)

Article

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders FundFounders Fund, and Max Levchin. 

Dawson Sewell
Dawson Sewell edited on 15 Aug 2018 3:22 pm
Edits made to:
Description (+209 characters)
Article (+1486 characters)
People (+4 rows) (+8 cells) (+137/-7 characters)
Further reading (+1 rows) (+4 cells) (+195 characters)
Categories (+3 topics)
Topic thumbnail

Emerald Therapeutics

Emerald Therapeutics offers cloud a based software and hardware platform, called the Emerald Cloud Lab, that allows scientists to perform automated experiments in a centralized lab from anywhere in the world.

Article



Emerald Therapeutics is a biotechnology company located in the San Francisco Bay Area, California and was founded in 2010 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab. The Emerald Cloud Lab provides researchers with total control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups.

Funding

Series A

On December 27, 2010 Emerald Therapeutics announced their series A funding round and closed with $7,500,000 in funding from James Hong. 

Series B

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders Fund, and Max Levchin. 

Series C

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound Ventures, Schooner Capital, OS Fund, and Founders Fund. 

People

Name
Role
Related Golden topics

Brian Frezza

Co-Founder



Brian Singerman

Board Member



DJ Kleinbaum

FounderCo-Founder



Gaetano Moreloo

Chief Scientific Officer and Board Member



Jimmy Demesa

CEO



Further reading

Author
Title
Link
Type

James Temple

Founders Fund Backs a Robotic Lab that Puts Science in the Cloud

News Article

Infobox

Categories

Edits on 7 Aug 2018
Jude Gomila
Jude Gomila edited on 7 Aug 2018 2:01 am
Edits made to:
People (+1 rows) (+2 cells) (+19 characters)

People

Name
Role
Related Golden topics

DJ Kleinbaum

Founder



Edits on 1 May 2018
Melanie Manipula
Melanie Manipula edited on 1 May 2018 10:17 pm
Edits made to:
Topic thumbnail

Emerald Therapeutics

Emerald Therapeutics is a biotechnology company located in San Fransisco, California, founded by Brian Frezza and DJ Klienbaum in 2010. Emerald Therapeutics offers cloud a based software and hardware platform that allows researchers to remotely perform automated scientific laboratory experiments.

Jude Gomila"Initial topic creation"
Jude Gomila created this topic on 1 May 2018 4:48 pm
Edits made to:
Topic thumbnail

 Emerald Therapeutics

Emerald Therapeutics is a biotechnology company located in San Fransisco, California, founded by Brian Frezza and DJ Klienbaum in 2010. Emerald Therapeutics offers cloud a based software and hardware platform that allows researchers to remotely perform automated scientific laboratory experiments.

No more activity to show.